The association between PSC and IBD

What is known

• Multiple reviews estimate IBD is present in about 70% of PSC cases, with one review citing around 75%. ^1–3
• One retrospective study reports the overall prevalence of IBD in PSC is 60–80%, with UC being the most frequently co-diagnosed IBD (80–90% of cases). ⁴
• PSC-IBD is characterized as a distinct phenotype with features such as extensive colitis, rectal sparing, backwash ileitis, and mild symptoms. ³
• The association is attributed to shared pathogenetic mechanisms involving intestinal barrier function, gut microbiota, immune response, and HLA haplotypes. ^1,2
• Both conditions share chronic inflammation, autoimmune pathogenesis, and increased malignancy risk (cholangiocarcinoma, colorectal cancer). ⁴

What is unknown / caveats

• Prevalence estimates reported as ranges (60–80%) and vary across studies and populations
• Several sources are narrative reviews rather than primary data
• The meta-analysis excerpt reports general-population PSC prevalence but the pooled PSC-in-IBD figure is not shown in the provided text
• The exact pooled prevalence of PSC within IBD populations is not stated in the provided meta-analysis excerpts.

References

1. Peviani M, Cazzagon N, Gambato M, Bertin L, Zingone F, Savarino EV, Barberio B. Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship. Minerva Gastroenterol (Torino). 2025. PMID: 38324328.

2. Da Cunha T, Vaziri H, Wu GY. Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review. J Clin Transl Hepatol. 2022. PMID: 35836773.

3. Hatami B, Pasharavesh L, Sharifian A, Zali MR. Concurrent inflammatory bowel disease and primary sclerosing cholangitis: a review of pre- and post-transplant outcomes and treatment options. Gastroenterol Hepatol Bed Bench. 2023;16:259-269. PMID: 37767322.

4. Mandea M, Oancea DM, Ghioca MC, Iacob SM, Iacob RA, Lupescu IG, Gheorghe LS. The Significance of Enzymatic Cholestasis in Inflammatory Bowel Disease Patients for the Diagnosis of Primary Sclerosing Cholangitis-A Retrospective Study. J Clin Med. 2025. PMID: 40869741.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.